The Cedars-Sinai Inflammatory Bowel and Immunobiology Research Institute (IBIRI) is searching for a Research Postdoc. IBIRI is a multidisciplinary basic, translational, and clinical research program devoted to Inflammatory Bowel Diseases. Under the direction of Dr. David Underhill, the institute is seeking a talented and highly motivated candidate to join our laboratory. The Underhill Laboratory is focused on understanding the molecular mechanisms by which some white blood cells, called macrophages and dendritic cells, recognize microbial pathogens and direct inflammation.
Find out more about Dr. Underhill's lab and research here:
An outstanding postdoctoral position is available in the Underhill laboratory at Cedars-Sinai Medical Center in Los Angeles to study mechanisms of innate immunity and host-microbe interactions. This dynamic group studies macrophage and dendritic cell biology, development of antimicrobial immune responses, and Inflammatory Bowel Disease (see Nature 472:47; Science 336:1314; Cell 166:624; Cell Host & Microbe 15:377). The successful candidate may study molecular mechanisms of interactions between microbes (fungi and bacteria) and phagocytes, or the role of the microbiome in influencing immune function and inflammatory diseases with a focus on fungal microbiota.
Recent Ph.D. graduates (within 3 years of graduating) with a strong background in animal models of inflammation and/or microbiome studies will be preferred. Experience in cell culture, molecular biology, flow cytometry, and mouse-handling is necessary. Strong communication skills and at least one peer-reviewed first author publication are required.
He or she will perform directed research project under the supervision of the PI and will devise experimental protocols and processes, compiles and analyzes data, develops figures, searches the scientific literature, assists in writing manuscripts, and presents data at local and national meetings. The successful candidate may study molecular mechanisms of interactions between microbes (fungi and bacteria) and phagocytes, or the role of the microbiome in intestinal diseases with a focus on fungal microflora.
Providing healthcare for more than 100 years, Cedars-Sinai has evolved into one of the most dynamic and highly renowned medical centers in the world. Along with caring for patients, Cedars-Sinai is a hub for biomedical research and a training center for future physicians and other healthcare professionals. This attracts exceptional talent to Cedars-Sinai, including world-renowned physician-scientists who seek a place where they can both conduct research and see patients--the ideal formula for discovery and its translation into cures. Our patients benefit from access to doctors at the top of their fields, and our researchers have an ideal community in which to study the impact of healthcare challenges, and reflect that knowledge in their research. The greater Los Angeles area in which Cedars-Sinai resides possesses unparalleled cultural and ethnic diversity which offers outstanding opportunities for translational and clinical research... and a dynamic environment for medical education.Although community based, Cedars-Sinai is a major teaching hospital affiliated with the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Cedars-Sinai has highly competitive graduate medical education programs in more than 50 specialty and subspecialty areas, a graduate program in biomedical sciences and translational medicine, a clinical scholars program directed towards junior physicians with aspirations to become clinical scientists, and post graduate training opportunities.There are more than 250 full-time faculty members at Cedars-Sinai. The voluntary medical staff, comprised of more than 2,200 specialty board-certified or board-qualified physicians, represent all of the specialties and subspecialties and collaborate with full-time medical staff in the teaching responsibilities of the graduate medical education programs.